Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1016/j.gastha.2021.12.006

http://scihub22266oqcxt.onion/10.1016/j.gastha.2021.12.006
suck pdf from google scholar
35174369!8818445!35174369
unlimited free pdf from europmc35174369    free
PDF from PMC    free
html from PMC    free
PDF vom PMID35174369 :   free
PDF vom PMID35174369

suck abstract from ncbi

pmid35174369
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • A Multiomic Approach of Saliva Metabolomics, Microbiota, and Serum Biomarkers to Assess the Need of Hospitalization in Coronavirus Disease 2019 #MMPMID35174369
  • Pozzi C; Levi R; Braga D; Carli F; Darwich A; Spadoni I; Oresta B; Dioguardi CC; Peano C; Ubaldi L; Angelotti G; Bottazzi B; Garlanda C; Desai A; Voza A; Azzolini E; Cecconi M; Mantovani A; Penna G; Barbieri R; Politi LS; Rescigno M
  • Gastro Hep Adv 2022[]; 1 (2): 194-209 PMID35174369show ga
  • BACKGROUND AND AIMS: The SARS-CoV-2 pandemic has overwhelmed the treatment capacity of the health care systems during the highest viral diffusion rate. Patients reaching the emergency department had to be either hospitalized (inpatients) or discharged (outpatients). Still, the decision was taken based on the individual assessment of the actual clinical condition, without specific biomarkers to predict future improvement or deterioration, and discharged patients often returned to the hospital for aggravation of their condition. Here, we have developed a new combined approach of omics to identify factors that could distinguish coronavirus disease 19 (COVID-19) inpatients from outpatients. METHODS: Saliva and blood samples were collected over the course of two observational cohort studies. By using machine learning approaches, we compared salivary metabolome of 50 COVID-19 patients with that of 270 healthy individuals having previously been exposed or not to SARS-CoV-2. We then correlated the salivary metabolites that allowed separating COVID-19 inpatients from outpatients with serum biomarkers and salivary microbiota taxa differentially represented in the two groups of patients. RESULTS: We identified nine salivary metabolites that allowed assessing the need of hospitalization. When combined with serum biomarkers, just two salivary metabolites (myo-inositol and 2-pyrrolidineacetic acid) and one serum protein, chitinase 3-like-1 (CHI3L1), were sufficient to separate inpatients from outpatients completely and correlated with modulated microbiota taxa. In particular, we found Corynebacterium 1 to be overrepresented in inpatients, whereas Actinomycetaceae F0332, Candidatus Saccharimonas, and Haemophilus were all underrepresented in the hospitalized population. CONCLUSION: This is a proof of concept that a combined omic analysis can be used to stratify patients independently from COVID-19.
  • ä


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    194 2.1 2022